Evaluating the efficacy of the hepatitis B vaccination in haemodialysis patients.

Background: The vaccination of dialysis patients against hepatitis B is a standard of care. Data suggests that seroconversion following this vaccination is poor in dialysis patients. Methods: The authors compared the response of 67 incident dialysis patients who had received the hepatitis B vaccination to that of healthy subjects. Results: The authors found that only 60% of haemodialysis patients vaccinated against hepatitis B developed an immune response. Conclusions: Haemodialysis patients have a suboptimal response to hepatitis B vaccinations as compared to that of general population. [ABSTRACT FROM AUTHOR]